BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1332690)

  • 1. Retinoblastoma protein phosphorylation does not require activation of p34CDC2 protein kinase.
    Evans GA; Farrar WL
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):965-9. PubMed ID: 1332690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
    Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
    J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca(2+)-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts.
    Takuwa N; Zhou W; Kumada M; Takuwa Y
    J Biol Chem; 1993 Jan; 268(1):138-45. PubMed ID: 8416921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle regulation of retinoblastoma protein phosphorylation.
    Lin BT; Wang JY
    Ciba Found Symp; 1992; 170():227-41; discussion 241-3. PubMed ID: 1483348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-purification of p34cdc2/p58cyclin A proline-directed protein kinase and the retinoblastoma tumor susceptibility gene product: interaction of an oncogenic serine/threonine protein kinase with a tumor-suppressor protein.
    Williams RT; Carbonaro-Hall DA; Hall FL
    Oncogene; 1992 Mar; 7(3):423-32. PubMed ID: 1532245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of p34cdc2 complex formation from phosphorylation and histone H1 kinase activity.
    Eblen ST; Fautsch MP; Burnette RJ; Snyder M; Leof EB
    Cancer Res; 1995 May; 55(9):1994-2000. PubMed ID: 7728771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells.
    Lucas JJ; Terada N; Szepesi A; Gelfand EW
    J Immunol; 1992 Mar; 148(6):1804-11. PubMed ID: 1541821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.
    DeCaprio JA; Furukawa Y; Ajchenbaum F; Griffin JD; Livingston DM
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1795-8. PubMed ID: 1531876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cdc2-like kinase is associated with the retinoblastoma protein.
    Kitagawa M; Saitoh S; Ogino H; Okabe T; Matsumoto H; Okuyama A; Tamai K; Ohba Y; Yasuda H; Nishimura S
    Oncogene; 1992 Jun; 7(6):1067-74. PubMed ID: 1594240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity.
    Abraham SE; Carter MC; Moran E
    Mol Biol Cell; 1992 Jun; 3(6):655-65. PubMed ID: 1323350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol ester TPA rapidly prevents activation of p34cdc2 histone H1 kinase and concomitantly the transition from G2 phase to mitosis in synchronized HeLa cells.
    Barth H; Kinzel V
    Exp Cell Res; 1994 Jun; 212(2):383-8. PubMed ID: 8187833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokinin controls the cell cycle at mitosis by stimulating the tyrosine dephosphorylation and activation of p34cdc2-like H1 histone kinase.
    Zhang K; Letham DS; John PC
    Planta; 1996; 200(1):2-12. PubMed ID: 8987615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deficiency in the mechanism for p34cdc2 protein kinase activation in mouse embryos arrested at 2-cell stage.
    Aoki F; Choi T; Mori M; Yamashita M; Nagahama Y; Kohmoto K
    Dev Biol; 1992 Nov; 154(1):66-72. PubMed ID: 1426634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of RCC1, a nuclear DNA-binding protein, uncouples the completion of DNA replication from the activation of cdc2 protein kinase and mitosis.
    Nishitani H; Ohtsubo M; Yamashita K; Iida H; Pines J; Yasudo H; Shibata Y; Hunter T; Nishimoto T
    EMBO J; 1991 Jun; 10(6):1555-64. PubMed ID: 1851087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression.
    Yamamoto M; Yoshida M; Ono K; Fujita T; Ohtani-Fujita N; Sakai T; Nikaido T
    Exp Cell Res; 1994 Jan; 210(1):94-101. PubMed ID: 8270002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase.
    Lin BT; Gruenwald S; Morla AO; Lee WH; Wang JY
    EMBO J; 1991 Apr; 10(4):857-64. PubMed ID: 2009861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the murine homologue of the cell cycle control protein p34cdc2 in T lymphocytes.
    Kim YH; Proust JJ; Buchholz MJ; Chrest FJ; Nordin AA
    J Immunol; 1992 Jul; 149(1):17-23. PubMed ID: 1637418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2-dependent phosphorylation of the retinoblastoma-susceptibility-gene product p110-115RB in human T-cells.
    Evans GA; Wahl LM; Farrar WL
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):759-64. PubMed ID: 1554358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell cycle.
    Gautier J; Matsukawa T; Nurse P; Maller J
    Nature; 1989 Jun; 339(6226):626-9. PubMed ID: 2543932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smooth muscle cell proliferation. Expression and kinase activities of p34cdc2 and mitogen-activated protein kinase homologues.
    Watson MH; Venance SL; Pang SC; Mak AS
    Circ Res; 1993 Jul; 73(1):109-17. PubMed ID: 8389675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.